Davis Andrew S.'s Form 4 filing
Silk Road Medical Inc (SILK) · filed Aug 4, 2023
- Accession no.
- 0001593968-23-001145
- Filed
- Aug 4, 2023
- Trade date
- May 19-Aug 3, 2023
- Filing delay
- 77 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $145.8K. It was filed 77 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Andrew S.CIK 0001770191 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 19, 2023 | Common Stock | AGrant or awardAcquired | +507 | $26.17 | +$13,268.19 | 116,121 | Direct | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −6,587 | $22.13 | −$145,770.31 | 109,534 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.